fda approval in nsclc, and ema regulatory advances in pancreatic cancer, nhl, and cll
Published 7 years ago • 161 plays • Length 6:27
Download video MP4
Download video MP3
Similar videos
-
0:31
preview: fda approval in nsclc and ema regulatory advances
-
7:59
fda approval in head and neck cancer, european approval in nsclc, and more
-
1:06
dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
-
8:07
fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
9:42
fda approval in lung cancer, promising findings in hodgkin lymphoma, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
0:31
preview: fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
0:46
fda approves capmatinib for advanced lung cancer
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
1:05
comparing dasatinib-blinatumomab vs ponatinib-blinatumomab in newly diagnosed ph b-all
Clip.africa.com - Privacy-policy